Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Neuronetics
STIM
$138M
| $580K | ﹤0.01% |
322,200
+178,700
| +125% | +$515K |
|
2627
Olema Pharmaceuticals
OLMA
$1B
| $576K | ﹤0.01% |
+53,200
| New | +$577K |
|
2628
Usio Inc
USIO
$58.8M
| $575K | ﹤0.01% |
375,656
-9,085
| -2% | -$14K |
|
|
BNT
2629
Brookfield Wealth Solutions
BNT
$11.8B
| $574K | ﹤0.01% |
20,700
-25,793
| -55% | -$717K |
|
2630
MicroSectors Gold Miners -3x Inverse Leveraged ETN
GDXD
$1.27B
| $573K | ﹤0.01% |
123
+101
| +459% | +$494K |
|
|
KLRS
2631
Kalaris Therapeutics
KLRS
$83.5M
| $572K | ﹤0.01% |
34,400
-3,056
| -8% | -$54K |
|
2632
Smart Sand
SND
$185M
| $571K | ﹤0.01% |
270,800
-10,100
| -4% | -$21.4K |
|
2633
OGE Energy
OGE
$9.78B
| $571K | ﹤0.01% |
16,000
-279,700
| -95% | -$9.82M |
|
2634
JPMorgan US Quality Factor ETF
JQUA
$8.21B
| $567K | ﹤0.01% |
10,700
-58,700
| -85% | -$3.04M |
|
2635
Five Point Holdings
FPH
$373M
| $566K | ﹤0.01% |
193,200
-1,500
| -0.8% | -$4.63K |
|
|
VXRT
2636
DELISTED
Vaxart
VXRT
| $566K | ﹤0.01% |
847,631
-76,669
| -8% | -$63.6K |
|
|
TRIB
2637
Trinity Biotech
TRIB
$7.83M
| $565K | ﹤0.01% |
8,848
-64
| -0.7% | -$3.73K |
|
2638
Gentherm
THRM
$1.25B
| $565K | ﹤0.01% |
11,464
-17,100
| -60% | -$884K |
|
|
AKRO
2639
DELISTED
Akero Therapeutics
AKRO
| $565K | ﹤0.01% |
+24,100
| New | +$515K |
|
2640
Pyxis Tankers
PXS
$48.7M
| $564K | ﹤0.01% |
110,795
+25,194
| +29% | +$123K |
|
2641
Monolithic Power Systems
MPWR
$70.1B
| $564K | ﹤0.01% |
686
-19,400
| -97% | -$14M |
|
|
ALLK
2642
DELISTED
Allakos
ALLK
| $562K | ﹤0.01% |
562,411
-293,307
| -34% | -$348K |
|
2643
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
| $562K | ﹤0.01% |
+22,700
| New | +$560K |
|
2644
HBT Financial
HBT
$1.3B
| $562K | ﹤0.01% |
27,500
+14,400
| +110% | +$274K |
|
|
TRST
2645
Trustco Bank Corp NY
TRST
$970M
| $561K | ﹤0.01% |
19,486
+927
| +5% | +$25.5K |
|
2646
Bally's
BALY
$682M
| $560K | ﹤0.01% |
+46,797
| New | +$598K |
|
|
QIPT
2647
DELISTED
Quipt Home Medical
QIPT
| $560K | ﹤0.01% |
173,900
-111,500
| -39% | -$400K |
|
2648
Goldgroup Mining Inc.
GORO
$157M
| $559K | ﹤0.01% |
1,496,390
+95,300
| +7% | +$46.5K |
|
|
RSVR
2649
DELISTED
Reservoir Media
RSVR
| $559K | ﹤0.01% |
70,700
+40,600
| +135% | +$324K |
|
|
REFI
2650
Chicago Atlantic Real Estate Finance
REFI
$248M
| $558K | ﹤0.01% |
36,300
+5,400
| +17% | +$84.5K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.